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Abstract
Sex determining region Y-box 2 (Sox2), a member of 
the SoxB1 transcription factor family, is an important 
transcriptional regulator in pluripotent stem cells (PSCs). 
Together with octamer-binding transcription factor 4 
and Nanog, they co-operatively control gene expression 
in PSCs and maintain their pluripotency. Furthermore, 
Sox2 plays an essential role in somatic cell reprogram-
ming, reversing the epigenetic configuration of differ-
entiated cells back to a pluripotent embryonic state. In 
addition to its role in regulation of pluripotency, Sox2 
is also a critical factor for directing the differentiation 
of PSCs to neural progenitors and for maintaining the 
properties of neural progenitor stem cells. Here, we 
review recent findings concerning the involvement of 
Sox2 in pluripotency, somatic cell reprogramming and 
neural differentiation as well as the molecular mecha-
nisms underlying these roles.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Sex determining region Y-box 2 (Sox2) plays 
important roles in pluripotent stem cells, not only for 
maintaining their pluripotency but also for directing 
their neural differentiation. There have been many 
intensive studies in the last decade, which serve to as-
certain the function of Sox2 in these processes. In this 
review, we have summarized the recent progress made 
regarding the involvement of Sox2 in pluripotency, 
somatic cell reprogramming and neural differentiation 
as well as the molecular mechanisms underlying these 
roles.
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INTRODUCTION
Human pluripotent stem cells (hPSCs), including human 
embryonic stem cells (hESCs) and induced pluripotent 
stem cells (iPSCs), possess two important properties: in-
definite self-renewal in culture and the ability to generate 
most, if  not all, cell types in the human body via differ-
entiation into one of  the three embryonic germ layers[1,2]. 
These unique properties of  hPSCs make them an invalu-
able cell resource not only for regenerative medicine, 
disease modelling and drug development, but also for 
the study of  early human development, serving as a cell 
model to elucidate the molecular mechanisms regulating 
embryonic cell proliferation and differentiation. Under-
standing the mechanisms underlying the self-renewal 
and differentiation of  hPSCs is fundamentally important 
for the subsequent utilization of  these cells. In the past 
TOPIC HIGHLIGHT
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.4252/wjsc.v6.i3.305
World J Stem Cells  2014 July 26; 6(3): 305-311
ISSN 1948-0210 (online)
© 2014 Baishideng Publishing Group Inc. All rights reserved.
305 July 26, 2014|Volume 6|Issue 3|WJSC|www.wjgnet.com
Sox2, a key factor in the regulation of pluripotency and 
neural differentiation
WJSC 6th Anniversary Special Issues (3): Embryonic stem cells
decade, increasing evidence has shown that cell fate de-
termination of  a pluripotent stem cell, either maintain-
ing pluripotency or differentiating into one of  the three 
germ layers, is controlled by both extrinsic and intrinsic 
factors[3]. Intrinsic factors refer mainly to transcription 
factors that play an essential role in the direct control of  
gene expression in cells, while extrinsic factors, includ-
ing growth factors, extracellular matrices and cytokines, 
have considerable effects on expression levels of  intrinsic 
transcription factors through various signalling pathways. 
The core intrinsic factors for regulating pluripotency 
have been identified as octamer-binding transcription 
factor 4 (Oct4), sex determining region Y-box 2 (Sox2) 
and Nanog[4,5], while Oct4 and Sox2 are also proposed as 
lineage specifiers to regulate mesendoderm and ectoderm 
differentiation, respectively[6,7]. Thus, Sox2 is one of  the 
critical factors that control both pluripotency and neural 
differentiation of  hPSCs. 
In this review, we place particular emphasis on the bi-
ological functions of  Sox2 in regulating pluripotency and 
early neural differentiation of  ESCs and summarize the 
recent findings on the role that Sox2 plays in the regula-
tion of  PSC fate.
SOX2 IS INDISPENSIBLE DURING EARLY 
EMBRYONIC DEVELOPMENT
Sox2 is a member of  the Sox family of  transcription fac-
tors. The Sox gene family was first defined by the discov-
ery of  the mammalian testis-determining factor, Sry[8,9]. 
Proteins of  the Sox family all share a highly conserved 
high-mobility-group (HMG) DNA binding domain. 
To date, 20 different Sox genes have been identified in 
mouse and human[10], which are divided into subgroups, 
according to the degree of  homology within the HMG 
domain and other structural motifs. Sox2 is classified as a 
member of  SoxB1 group, which also includes Sox1 and 
Sox3. Although Sox1, Sox2 and Sox3 share more than 
80% sequence similarity and are functionally redundant, 
Sox2 can exert distinct functions in a biologically context-
dependent manner and is indispensable for embryonic 
development. Many factors have been shown to influence 
binding of  Sox proteins to their target genes, leading to 
diverse functional effects. One such factor is the interac-
tion between Sox proteins and various cofactors. Interac-
tion with various cofactors confers upon Sox2 greater 
functional versatility during developmental processes[11]. 
During mouse embryogenesis, a totipotent zygote 
undergoes cleavage to increase the cell number and the 
resulting multi-cellular morula further develops to form 
the blastocyst, in which the cells, for the first time, appear 
to acquire spatially derived identities, segregating into the 
inner cell mass (ICM) and trophectoderm. Cells in the 
ICM give rise to the embryo proper, differentiating into 
all cell types found within the body and are thus classi-
fied as pluripotent. Conversely, trophoblast cells develop 
into placental tissues, assisting with implantation and 
nourishment of  the embryo during development. Sox2 
expression is initially detected in cells at the morula stage, 
becoming more specifically located in the ICM of  blasto-
cyst and epiblast[12] during the latter stages. This implies 
that Sox2 may have important roles in the formation of  
early pluripotent embryonic cells. Indeed, zygotic deletion 
of  Sox2 is embryonically lethal due to the failure to form 
pluripotent epiblast whilst the absence of  Sox2 has little 
effect on the formation of  trophectoderm[12]. Therefore, 
Sox2 is an essential factor in the formation of  pluripotent 
cells in early embryos and ultimately an critical factor for 
embryonic development.
CRITICAL ROLE OF SOX2 IN 
MAINTAINING PLURIPOTENCY OF ESCS 
AND GENERATION OF IPSCS
ESCs, derived from the ICM of  preimplantation em-
bryos, share many characteristics with the ICM cells. 
One major similarity is their pluripotent capability, be-
ing able to give rise to all cell types of  the adult body. 
However, ESCs are not identical to the cells in the ICM 
as ESCs are able to amplify themselves during extended 
culture without compromising their pluripotency. Con-
sistent with the data in pre-implantation embryos, Sox2 
is highly expressed in ESCs. Depletion of  Sox2 by ei-
ther gene-knockout or RNA interference considerably 
compromises the pluripotent state of  both mouse and 
human ESCs as shown by the changes in cell morphol-
ogy, loss of  pluripotent marker expression and their dif-
ferentiation primarily into trophectoderm[2,13]. However, 
forced expression of  Oct4 in Sox2-null mouse ESCs 
(mESCs) can rescue the pluripotency of  these cells, 
indicating that the role of  Sox2 in maintaining the plu-
ripotent state of  ESCs is primarily to sustain a sufficient 
level of  Oct4 expression[2,13]. Collectively, these results 
demonstrate that Sox2 is crucial in the maintenance 
of  pluripotent ESCs, possibly through promoting and 
maintaining Oct4 expression.
Interestingly, to maintain pluripotency of  stem cells, 
levels of  Sox2 expression need to be stringently regu-
lated, with either higher or lower Sox2 expression leading 
to the loss of  pluripotency in ESCs. This could be at-
tributed to the fact that both low and high levels of  Sox2 
reduce the promoter/enhancer activity of  Sox2-Oct4 tar-
get genes[14,15]. The expression level of  Sox2 needs to be 
retained in a dynamic equilibrium with other synergistic 
factors in order to maintain pluripotency. This concept is 
also supported by the finding that Sox2 cooperates with 
other highly dose-dependent transcription factors, such 
as Oct4 and Nanog, in the regulation of  pluripotency[4]. 
In human and mouse ESCs, Oct4, Sox2 and Nanog form 
a core transcriptional regulatory circuitry in pluripotent 
stem cells to maintain their self-renewal. Oct4 and Sox2 
co-occupy a large number of  enhancers/promoters and 
regulate the expression levels of  their target genes (Figure 
1). They activate the expression of  pluripotent genes, in-
cluding Nanog and themselves, whilst repressing the ex-
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pression of  key genes that are responsible for the in vitro 
differentiation and in vivo developmental processes, such 
as paired-box protein 6 (Pax6) and gastrulation brain 
homeobox 2[4,5]. These transcriptional regulatory activi-
ties of  Sox2 and Oct4 have been shown to require their 
direct interaction[16]. The cooperative interaction between 
HMG of  Sox2 and pit-oct-unc (POU) homeodomain of  
Oct4 is thought to be critical in regulation of  ESC pluri-
potency[17].
IPSCs are generated from various somatic cell types 
by ectopically expressing transcription factors that are 
important for ESC pluripotency. The most commonly 
used factors are Oct4, Sox2, Kruppel-like factor 4 (Klf4) 
and c-Myc[18]. These factors are able to reprogram the 
somatic cells back to their embryonic state, making them 
share the dual properties of  pluripotency and long-term 
self-renewal much like their ESC counterparts. Given 
that Sox2 is essential in the maintenance of  pluripotency 
in ESCs, it is conceivable that Sox2 is one of  the key 
factors for the generation of  iPSCs[18]. In fact, by analys-
ing gene expression profile on a single cell level during 
reprogramming, it has been found that the activation of  
endogenous Sox2 is a relative early event, which initi-
ates a cascade of  transcriptional changes, leading to the 
formation of  iPSCs[19]. Interestingly, based on the shared 
biological properties between SoxB1 genes, Sox2 can be 
replaced by closely related Sox family members, Sox1 and 
Sox3, in the generation of  iPSCs, but not by more distant 
members, like Sox7 and Sox15[20]. However, it has been 
reported that Sox17 is able to replace Sox2 in the suc-
cessful generation of  iPSCs after it is genetically modified 
in which two amino acids in the Sox17 HMG domain 
are converted to those of  Sox2. This conversion does 
not alter Sox17 HMG DNA binding motif  but confers 
its ability to interact with Oct4. The modified Sox17 is 
able to interact with Oct4 and the resulting Sox17-Oct4 
complex can cooperatively bind to the canonical subset 
of  Sox-Oct motifs and successfully reprogram somatic 
cells[21]. Taken together, Sox2 is therefore important for 
the successful reprogramming of  somatic cells to iPSCs. 
As such, the physical interaction between Sox2 and Oct4 
is likely to be critical in induction and maintenance of  
pluripotency.
SOX2 IN NEURAL DIFFERENTIATION 
AND MAINTENANCE OF NEURAL 
PROGENITOR/STEM CELLS 
During embryonic development, Sox2 is persistently 
expressed, initially in the epiblast of  preimplantation em-
bryos, then more predominantly in the central nervous 
system after gastrulation, hinting at a possible function 
for Sox2 in neural commitment[22]. Recently, it has been 
suggested that the three core pluripotent transcription 
factors Sox2, Oct4 and Nanog not only play an important 
role in the induction and maintenance of  pluripotency, 
but also in functioning as lineage specifiers, regulating 
the differentiation of  ESCs to specific lineages[6,23]. Sox2 
governs ESC specification to neuroectoderm while Oct4 
and Nanog promote their differentiation to mesendo-
derm, a common precursor of  mesoderm and definitive 
endoderm[7]. Sox2 induces neural induction and enhances 
neural differentiation by repressing key regulators of  oth-
er lineage fates, for example brachyury[7,23,24]. Therefore, 
Sox2 appears to be an important regulator in controlling 
PSC neural initiation and differentiation. 
In addition to its role in regulating neural induction, 
Sox2 also functions to maintain the self-renewal of  neu-
ral progenitor stem cells in vitro as well as in vivo. Sox2 is 
highly expressed in proliferating neural progenitor cells 
(NPCs) and is downregulated upon differentiation to 
post-mitotic neuronal and glial cells. Reduction of  Sox2 
in neural progenitor stem cells hinders their self-renewal 
and proliferation, promoting their earlier exit from cell 
cycle and terminal differentiation; whereas ectopic ex-
pression of  Sox2 inhibits the differentiation of  NPCs 
into neurons and glia[25,26]. The fact that ectopic expres-
sion of  Sox2 alone or in combination with other neural 
transcription factors can directly reprogram fibroblasts 
to multipotent neural progenitor stem cells further high-
lights the essential role Sox2 plays in these cells[27,28]. 
Taken together, Sox2 is therefore a key factor in both 
the establishment and maintenance of  neural progenitor 
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Figure 1  Sex determining region Y-box 2 regulates gene expression in pluripotent stem cells and neural progenitor/stem cells. Sex determining region Y-box 
2 (Sox2) interacts with Oct4 and other nuclear factors to activate pluripotent gene expression and repress differentiation gene expression in pluripotent stem cells. In 
neural progenitor/stem cells, Sox2 interacts with neural transcription factors, such as Brn2 and Pax6, to activate neural progenitor gene expression. Oct4: Octamer-
binding transcription factor 4; Pax6: Paired-box protein 6.
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transforming growth factor beta signalling pathway which 
is required for hESC maintenance[36]. In NPCs, Sox2 ex-
pression is promoted by transcriptional factors that are 
highly expressed during neural development and differen-
tiation, such as activating protein 2, prospero homeobox 
protein 1 and Pax6[29]. Signalling pathways, such as phos-
phatidylinositol-4,5-bisphosphate 3-kinase/Akt and Stat3, 
also function to regulate Sox2 expression[37,38]. Recently, 
cell cycle regulators E2f3a and E2f3b have been reported 
to regulate Sox2 expression and control neural progenitor 
cell proliferation in adult brain[39,40]. E2f3a and E2f3b are 
shown to differentially regulate Sox2 expression in neu-
ral progenitor cells, thus affecting adult neurogenesis[39]. 
E2f3a cooperates with the pRb family member p107 to 
repress Sox2 expression, reducing neural progenitor self-
renewal and promoting terminal differentiation, whereas 
E2f3b activates Sox2 expression by recruiting RNA 
polymerase Ⅱ to its promoter, leading to increased self-
renewal and neural progenitor/stem cell expansion. Cy-
clin-dependent kinase inhibitor P21 has also been found 
to directly bind to a Sox2 enhancer and repress Sox2 
expression in NPCs[40]. The various enhancers/regulatory 
regions of  Sox2 work together to stringently regulate the 
expression of  Sox2 from early preimplantation embryos 
to various neural progenitor cells[30,35,41]. 
Other than transcriptional regulation, Sox2 expres-
sion and activity are also regulated by post-transcriptional 
and translational mechanisms. MicroRNA-145 has been 
demonstrated to negatively affect the expression of  plu-
ripotent transcription factors, including Oct4, Sox2 and 
Klf4[42]. Sox2 protein can be modulated by methylation, 
acetylation, sumoylation and phosphorylation, which sub-
sequently affect its activities as a transcriptional regulator. 
Three phosphorylation sites, S249, S250 and S251, have 
been identified in Sox2, the phosphorylation of  which 
promotes sumoylation of  Sox2, subsequently inhibiting 
the binding of  Sox2 to DNA motifs[43,44]. Acetylation of  
Sox2 by a histone acetyltransferase, p300, induces its nu-
clear export in ESCs, leading to increased ubiquitination 
and proteasomal degradation of  Sox2 protein[45]. 
Sox2 regulates distinct target genes in pluripotent 
ESCs and during neural differentiation. Although the ex-
act mechanisms that govern its selection on target genes 
are not fully elucidated, transcription factors that function 
as Sox2 interacting partners may play an important role 
in this selection. Sox2 is similar to all Sox family mem-
bers, in that achieving their regulatory functions requires 
properties.
MOLECULAR MECHANISMS 
UNDERLYING THE ROLES OF SOX2 
IN PLURIPOTENCY AND NEURAL 
DIFFERENTIATION
In the last decade, intensive studies have been carried 
out in order to elucidate the molecular mechanisms that 
control pluripotency and lineage specification. Although 
considerable progress has been made, the mechanisms 
are still not fully understood. Given that Sox2 functions 
in both PSCs and NPCs, it is thought that stringently reg-
ulated Sox2 expression is necessary to govern both pluri-
potency and initiation of  neural differentiation in PSCs. 
Furthermore, differentially orchestrated mechanisms are 
required to control distinct functions of  Sox2 in self-
renewal of  PSCs and during their neural differentiation.
Like other transcription factors, the expression of  
Sox2 is regulated by both intrinsic factors and extrinsic 
signalling pathways. It has been identified that several 
regulatory regions in the Sox2 locus are responsible for 
controlling Sox2 expression, which include Sox2 core 
promoter[29] and a number of  enhancers located both up-
stream and downstream of  the Sox2 gene (Figure 2)[30-33]. 
All of  these regulatory regions are highly conserved 
across species, responding to different factors and signal-
ling pathways[30]. In ESCs, several laboratories have clearly 
demonstrated that Sox2 interacts with Oct4 to form 
a regulatory complex, which binds to Sox2 regulatory 
region 2 to activate Sox2 transcription[4,5,34,35], indicating 
that Sox2 is positively auto-regulated by the Sox2-Oct4 
complex in ESCs. In addition to Oct4, several other tran-
scriptional factors, including Nanog, mothers against de-
capentaplegic homolog 1 (Smad1) and signal transducer 
and activator of  transcription 3 (Stat3), are also identified 
to be involved in the formation of  the autoregulatory 
complex in mESCs, which activate Sox2 as well as other 
pluripotent genes[5]. In this complex, State3 and Smad1, 
which are the key components of  the bone morpho-
genetic protein and leukemia inhibitory factor signal-
ling pathways of  mESCs, allow the core transcriptional 
network integrated into external signalling pathways of  
mESCs. In hESCs, Sox2-Oct4 complex co-occupies their 
target genes with mothers against decapentaplegic ho-
molog 3 (Smad3) protein, a downstream effector of  the 
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Figure 2  Transcriptional expression of sex determining region Y-box 2 is regulated by multiple enhancers located in the sex determining region Y-box 2 
locus. The sex determining region Y-box 2 (Sox2) gene locus is illustrated in yellow box, in which Sox2 exon and location of the N1 to N5 enhancers are indicated. 
TSS and TTS represent transcription starting and termination sites, respectively. SRR1 and 2 are Sox2 regulatory regions 1 and 2.
Untranslated region                  Sox2 coding region
N3                 N2            Promoter       TSS                                                           TTS              N5                 N1             N4
HMG
SRR1                                                                                                                     SRR2
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pairing and coordination with other transcription factors 
to form complexes[46]. The Sox transcription factor and 
its interacting partner bind to adjacent DNA sequences 
in promoter/enhancer of  target genes to regulate their 
expression. Several Sox2 partners have been identified in 
various cell types (Table 1)[4,34,35,41,47-50]. The most studied 
Sox2 partner is Oct4 in PSCs. As discussed earlier, Sox2 
has been shown to interact directly with Oct4 in PSCs 
and the Sox2-Oct4 complex binds to adjacent DNA mo-
tifs located in the enhancer/promoter regions of  thou-
sands of  genes genome-wide to either activate or repress 
the expression of  these genes. They cooperatively acti-
vate pluripotent genes whilst repressing lineage-specific 
ones, hence maintaining pluripotency in these cells (Figure 
1)[4,34,35]. However, it is less clear which transcription fac-
tors serve as the Sox2 binding partners during the neural 
differentiation of  PSCs. In early murine neural progeni-
tors, Sox2 is shown to interact with the brain-specific 
POU domain-containing transcription factor Brn2 to 
activate the NPC-associated Nestin gene expression[48]. 
During lens development, Sox2 and Pax6 form a com-
plex which binds to lens-specific enhancer elements to 
initiate lens development[41]. Recently, it is also reported 
that Sox2 is able to interact with long non-coding RNA 
rhabdomyosarcoma 2 associated transcript to activate the 
expression of  their neural target genes and to promote 
neural differentiation[51]. It is possible that Sox2 requires 
different partners in different neural progenitor cells, 
which regulate expression of  different gene sets, leading 
to the formation of  different neural cell types. 
CONCLUSION
Sox2 is one of  the key transcription factors that play an 
essential role in maintaining pluripotency of  stem cells. 
Sox2 interacts with Oct4 to form a binary complex, which 
then recruits other nuclear factors to activate pluripotent 
gene expression and repress genes involved in differentia-
tion. Furthermore, Sox2 is also a critical factor for initiat-
ing the neural induction and maintaining neural progeni-
tor stem cell properties throughout neural differentiation. 
Recently, it has been reported that Sox2 is expressed in 
adult stem cells of  several epithelial tissues and regulates 
trophoblast stem cell differentiation[47,52]. However, how 
Sox2 achieves these pleiotropic functions remains to be 
elucidated. Sox2, like other Sox family members, performs 
its regulatory functions more efficiently when paired with 
an interacting partner. Although Oct4 has been well dem-
onstrated as being such a partner in pluripotent stem cells, 
the identities of  Sox2 partners in other tissues are largely 
unknown. Understanding the molecular mechanisms gov-
erning Sox2 functions will facilitate the use of  pluripotent 
stem cells for clinical and biomedical applications, with 
particular relevance to the modelling and treatment of  
various neurological disorders.
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